|Year : 2007 | Volume
| Issue : 1 | Page : 18-22
|Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough
Amina Hamed Ahmad Al Obaidi
Department of Biochemistry, College of Medicine, Tikrit University, Tikrit, Iraq
Amina Hamed Ahmad Al Obaidi
Department of Biochemistry, College of Medicine, Tikrit University, Tikrit
| Abstract|| |
The reported studies suggest a role for eosinophils in the pathogenesis of cough variant asthma. In the present study, the expired breath condensate level of hydrogen peroxide and pH were determined in patients with cough variant asthma and compared to subjects with classical asthma, with chronic cough nonasthmatic and healthy control. Twenty-seven patients with cough variant asthma, 43 patients with classical asthma, 32 patients with chronic cough and 27 healthy subjects were studied in a cross-sectional study. Hydrogen peroxide concentration was significantly higher in cough variant asthma as compared to chronic cough nonasthmatic patients and healthy control subjects, while pH level was significantly lower in cough variant asthma as compared to chronic cough nonasthmatic patients and healthy control subjects. However, there was no significant difference in expired breath condensate hydrogen peroxide and pH between cough variant asthma and classical asthma. In conclusion, hydrogen peroxide concentration and pH of expired breath condensate may be used as noninvasive markers to differentiate cough variant asthma from chronic cough.
Keywords: Asthma, chronic cough, cough variant asthma, hydrogen peroxide, pH
|How to cite this article:|
Ahmad Al Obaidi AH. Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough. Ann Thorac Med 2007;2:18-22
|How to cite this URL:|
Ahmad Al Obaidi AH. Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough. Ann Thorac Med [serial online] 2007 [cited 2021 Sep 23];2:18-22. Available from: https://www.thoracicmedicine.org/text.asp?2007/2/1/18/30357
Chronic nonproductive cough resistant to antibiotics and the usual antitussive agents is a common problem in the pulmonary clinics. Of those patients whose chronic cough goes undiagnosed, 30 -50% of those patients have unrecognized or cough variant asthmatics. However, cough may be the sole manifestation of asthma., Corrao et al in 1979 reported that six subjects complaining of chronic persistent cough without wheezing or dyspnea and their cough soon disappeared after starting either bronchodilators but recurred when they were stopped. The authors regarded these subjects as having a variant form of asthma, which was named, cough variant asthma (CVA). Several reports on CVA followed then and the condition now recognized as a common cause of chronic cough.,
Recent research has clarified that asthma is a chronic inflammatory airway disease, in which eosinophils play a central role, consequently mediators released that lead to bronchoconstriction., Previous studies indicated increase in eosinophils in peripheral blood, sputum, bronchoaleveolar lavage fluid and bronchial mucosa.,,, The intensity of eosinophilic inflammation correlates with clinical severity of the disease, bronchial hyperresponsiveness and lung function.,,, Only four studies, to our knowledge, have examined the relationship between CVA and inflammation.,,, These reports suggest a role of eosinophils in the pathogenesis of CVA.
Activation of inflammatory cells and particularly eosinophils, is the prominent feature of airway inflammation in patients with asthma. Eosinophils release several mediators, including hydrogen peroxide that may amplify the inflammatory process in the airways. Eosinophils are activated both locally in the lungs and in the blood. As a consequence for hydrogen peroxide release, tracheal smooth muscle stimulated and contract, followed by stimulation of cough receptors to induce cough.
There is a relatively close association between inflammation and low pH which is shown by the further fall in pH during exacerbation. The drop in airway pH before and during asthma exacerbation would cause extensive eosinophils necrosis with an acute release of inflammatory and bronchoconstricting products, followed by induction of cough. Thus exhaled breath condensate acidification could be representative of an airway pH homeostatic alteration that underlies some or much of the pathology of lung diseases including inflammation in asthma. The hypothesis that was suggested, there was a positive association between exhaled breath condensate hydrogen peroxide concentration and pH in cough variant asthma and present in chronic cough patient. Therefore, utility of these two noninvasive markers of airway inflammation was evaluated in cough variant asthma and have compared to their levels in patients with classical asthma chronic cough and healthy control.
| Materials and Methods|| |
Twenty seven patients with CVA, 43 patients with classical asthma, 32 patients with chronic cough and 27 healthy subjects were studied in a cross-sectional study. The study was performed during the period from April 2005 to August 2006. The patients with CVA referred to Allergy and Asthmology Center in Tikrit Teaching Hospital for chronic cough persisting for longer than two months duration but without wheezing or dyspnea. They had no past history of asthma or other respiratory diseases. Wheeze or rhonchi were not audible on chest auscultation even at forced expiration. Bronchodilators (inhaled B agonist and/or oral theophyllines) were effective against their cough. No other apparent causes of cough were present, they did not have any sign or symptoms of postnasal drip or gastro - oesophegeal reflux, had not taken angiotensin converting enzyme inhibitors and had normal chest radiograph results.
The patients with classic asthma had a history of episodic dyspnea, wheezing and cough. They had at least 15% reversibility of forced expiratory volume in one second (FEV1) after inhalation of 200 mg of salbutamol. The control subjects had no past history of asthma or other respiratory diseases and had no current respiratory symptoms. Each patient with CVA or classic asthma had been treated with inhaled B agonist (used as needed) and/or theophylline taken twice daily. Treatment with B agonist was withheld for eight hours prior to the test of FEV1. Treatment with theophylline was withheld for 48 hours prior to all examinations. None of the studied subjects had ever taken systemic corticosteroids, cromoglycate or other antiallergic agents, had smoked within the previous two years or had respiratory infections for the last eight weeks. Thirty two patients with chronic cough and not asthmatic were included as chronic cough control. Asthma diagnosis was according to National Heart, Lung and Blood Institute guidelines for the diagnosis and management of asthma.
The study was approved by the ethics committee of our college and written consent was obtained from all participating subjects.
Lung function test
Lung function was measured by dry spirometry.
Hydrogen peroxide measurement
Expired breath condensate was collected by using a glass condensing device that was placed in a large chamber with ice. After rinsing their mouth, subjects breathe tiedly with normal frequency through a mouthpiece for 20 minutes while wearing a nose clip. H 2 O 2 assay was carried out by using colorimetric assay as described previously. Briefly, 100 µl of condensate was mixed with 100 ml of tetramethylbenzidine in 0.42 mol/l citrate buffer, pH 3.8 and 10 ml of horseradish peroxidase (52.5 U/ml). The samples were incubated at room temperature for 20 minutes and reaction was stopped by addition of 10 µl 18N sulfuric acid. The reaction product was measured spectrophotometrically at 450 nm. A standard curve of H 2 O 2 was performed for each assay.
Expired breath condensate pH was measured as previously described right after the collection of the condensate by using a pH meter (HI 8424).
Data concerning the comparisons among the various parameters in the study groups are given as mean (SD) with 95% confidence intervals for the differences. Student's unpaired two-tailed test was used for significant testing.
| Results|| |
Expired breath condensate hydrogen peroxide in cough variant asthma was significantly higher (0.83 ± 0.34 mmol, 95% CI 0.69-0.96 mmol, P <0.0001), than that for nonasthmatic chronic cough (0.24 ± 0.22 mmol, 95% CI 0.16-0.32 mmol) and healthy control (0.29 ± 0.07 mmol, 95% CI 0.27-0.31 mmol, P < 0.0001). However, there was no significant difference in exhaled breath condensate H 2 O 2 concentration between cough variant and classical asthma [Table - 1].
The exhaled breath condensate pH was significantly lower in cough variant asthma (6.26 ± 0.43, 95% CI 6.09-6.43, P <0.0001) than that for nonasthmatic chronic cough (7.32 ± 0.6, 95% CI 7.1-7.54) and healthy control (7.82 ± 0.65, 95% CI 7.61-7.99, P <0.0001). However, pH was lower in classical asthma as compared to that in cough variant asthma, but the difference did not reach significant value.
H 2 O 2 exhaled breath concentration and pH not significantly different between healthy control subjects and nonasthmatic patients with chronic cough.
| Discussion|| |
The inflammatory cells recruited to the asthmatic airways have an exceptional capability for producing reactive oxygen species including hydrogen peroxide. The oxidative injury caused by eosinophils can be substantial because the cells possess several times greater capacity to generate hydrogen peroxide than neutrophils. The reported studies indicated that hydrogen peroxide concentrations and eosinophils numbers were increased in exhaled breath condensate of asthmatic patients.,,,,
Cough variant asthma was first described by Glauser in 1972. The only presenting symptoms are isolated chronic cough responsive to bronchodilator treatment. Recognition of cough variant asthma is clinically important because bronchodilator treatment is only effective in cough variant asthma and can be prevented from progression to classical asthma. Bronchodilators usually exert no antitussive effect in other cases of isolated chronic cough. Thus for the purpose of effective treatment of chronic cough, there was a need for differentiating cough variant asthma from other cough entity.
In the present study, patients with cough variant asthma show high level of expired breath condensate H 2 O 2 than that in patients with chronic cough nonasthmatic and healthy control. Furthermore, expired breath condensate pH was lower in cough variant asthma than that in patients with chronic cough nonasthmatic subjects and healthy control. However, the expired breath condensate H 2 O 2 and pH in cough variant asthma were not significantly different from values for patients with classical asthma. In addition, expired breath condensate H 2 O 2 and pH were not with significant difference between healthy control and patients with nonasthmatic chronic cough. The increased expired breath condensate H 2 O 2 and decreased pH indicate the involvement of eosinophilic inflammation in cough variant asthma, as well as confirm the results of previous studies on the relationship between eosinophils and classic asthma. This was suggested depending on that patients with CVA have a high number of eosinophils in bronchoalveolar lavage fluid and bronchial tissue and increased serum eosinophil cationic protein as compared to healthy control. In addition, activation of inflammatory cells and particularly eosinophils, is a key feature of asthmatic inflammation, and may be reflected by increased hydrogen peroxide concentration in exhaled breath condensate.
The correlation of inflammation to cough in cough variant asthma is not clear. O'Conell et al have hypothesized that patients with cough variant asthma might have inflammation solely in the large airways, where cough receptors are abundant. Woolcock has also stated that cough receptors are assumedly stimulated by the inflammatory process and the cough in cough variant asthma will be mediated by in the central ways. Niimi et al performed bronchial biopsy at segmental bronchi, relatively central airways and broncho aleveolar lavage, which might reflect the inflammation of the whole airways from sub segmental bronchi to alveoli. Both procedures, however, revealed no differences between classic asthma and cough variant asthma and this evidence that strengthen our finding in this study. The site of inflammation may not be causally related to the difference in presenting manifestations from these results. Examinations at more central airways are required in a future study to elucidate this issue. Tussive mediators which are secreted from eosinophils may be possible mechanisms for the induction of cough in cough variant asthma.,
Another studies reported on several patients with chronic cough with normal pulmonary function tests and normal bronchial responsiveness. These patients showed an increase in eosinophil as well as metachromatic cells in sputum. After treatment with inhaled corticosteroids, cough decreased markedly and bronchial responsiveness improved in some patients. The authors labeled these patients as "eosinophilic bronchitis without asthma". The presence of bronchial responsiveness in cough variant asthma but not in eosinophilic bronchitis in the studies of Gibson et al, is difficult to explain, since eosinophilic inflammation, an essential cause of bronchial responsiveness in asthma,,, is present in both conditions. The differences in the intensity of inflammation, degree of activation of eosinophil, the initial level of bronchial responsiveness, the location of inflammation, may influence the variation between two conditions. These suggestions may explain the differences in expired breath condensate H 2 O 2 and pH between cough variant asthma and chronic cough patients as this study indicated.
The mechanisms of cough in asthma have been discussed in view of airflow obstruction. It was proposed that cough receptors are stimulated by local bronchoconstriction. As bronchodilators are effective against cough in cough variant asthma, this may be a possible pathogenetic mechanism. Cough may be the predominant symptom during exacerbation in some asthmatic patients. Pulmonary function test revealed narrowing of the central airways, whereas another group of asthmatics, who predominantly complained from dyspnea, had narrowing of the peripheral airways, thus the predominance of cough was due to central airway obstruction. Other studies on cough variant asthma, however, showed almost normal pulmonary function,, or peripheral rather than central airway obstruction at baseline. Examinations after methacholine challenge or exercise revealed obstruction of both central and peripheral airways, as seen identically in classic asthma or obstruction predominantly the peripheral airways. In the study of Niimi et al , the parameters of baseline pulmonary function, including indices of both central and peripheral responsiveness, did not significantly differ between classic and cough variant asthmatic patients.
The finding of the present study was in consistent with that of Niimi, which indicate no significant difference in expired breath condensate H 2 O 2 and pH as markers of inflammation and oxidative stress between cough variant and classic asthmatic patients. It is thus not certain whether the site of airflow obstruction or degree of bronchial responsiveness is causally related to differences in presenting manifestations. One possible mechanism for cough without wheeze in cough variant asthma is proposed by Koh et al . They demonstrated a higher wheezing threshold to inhaled methacholine in cough variant asthma than in classic asthma. Heightened cough receptor sensitivity may also be a mechanism  but some negate this possibility and the issue is still controversial.
The prevalence of asthma is increasing worldwide. However, the disease is still under-diagnosed. Recognition of cough variant asthma in the differential diagnosis of patients with chronic cough is quite important from clinical standpoint,,, although it's pathogenetic have not yet been fully elucidated. Appropriate diagnostic procedures, including detection of inflammatory markers in expired breath condensate should be considered. The presence of elevated H 2 O 2 and reduced pH of expired breath condensate, which may suggest eosinophilic airway inflammation and possible diagnosis of cough variant asthma, may be of some help in the initial assessment of patients with chronic cough.
Irreversible pathological changes of airway in asthmatic patients due to under treatment of the disease, is assumed to be due to persistent inflammation. Such irreversible changes may occur also in cough variant asthma, since inflammation is present in the airways of patients with cough variant asthma, as demonstrated in this study. Early introduction of inhaled corticosteroids may lead to better prognosis in cough variant asthma, as reported for classic asthma. However, this suggestion needs to be investigated in future studies.
Nearly 30% of patients with cough variant asthma may develop classic asthma., It is noteworthy that the rate of onset of typical asthma was significantly lower in patients treated with beclomethasone dipropionate inhaler, which suggests the usefulness of long term inhaled steroids as an intervention against cough variant asthma. Thus early diagnosis and intervention are important in controlling asthma. As cough variant asthma is thought to be precursor of typical asthma, early intervention for cough variant asthma may be as important as in mild asthma. A diagnosis of cough variant asthma has been made based on the efficacy of steroids by some investigators,,,, but steroids are effective not only in cough variant asthma but also in atopic cough. It is therefore likely that the use of steroids efficacy as a criterion to diagnose cough variant asthma may accidentally misclassify patients who actually have atopic cough. This may account for the increased cough sensitivity in patients with cough variant asthma studied by McGarvey and colleagues.
| Conclusion|| |
Determination of hydrogen peroxide concentration and pH of exhaled breath condensate indicate that they were significantly different between cough variant asthma and chronic cough in nonasthmatic patients. However, there were no significant differences between cough variant asthma and classical asthma in relation to values of hydrogen peroxide and pH in expired breath condensate. Thus it was recommended that it is important to use pH and H 2 O 2 expired breath condensate concentration as a criterion to help in diagnosis of cough variant asthma.
| References|| |
|1.||Al - Obaidy AH, Al Samarai AG. Exhaled breath condensate pH and hydrogen peroxide as non Invasive markers for asthma Saudi Med J. The alternative for this reference is Al - Obaidy AH. Validity Assessment of Different Biochemical Parameters in Patients with Bronchial Asthma. Ph D Thesis. Tikrit University College of Medicine: 2006. |
|2.||Morice AH, Kastelik JA. Cough. 1: Chronic cough in adults. Thorax 2003;58:901-7. |
|3.||Niimi A, Amitani R, Suzuki K, Tanak AE, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11:1064-9. |
|4.||Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Eng J Med 1979;300:633-7. [PUBMED] |
|5.||Hannaway PJ, Hopper GD. Cough variant asthma in children. JAMA 1982;247:206-8. [PUBMED] |
|6.||O'Connel EJ, Rojas AR, Sachs MI. Cough type asthma: A review. Ann Allergy 1991;66:278-85. |
|7.||Bjornsdottir US, Quan SF, Busse WW. Eosinophils and asthma. In: Busse WW, Holgate ST, editor. Asthma and rhinitis. Blackwell Scientific Publications: Boston; 1995. p. 328-46. |
|8.||Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-9. |
|9.||Kirby JG, Hargreave FE, Gleich GJ, O' Byrne PM. Bronchoalveolar cell profiles of asthmatic and no asthmatic subjects. Am Rev Respir Dis 1987;136:379-83. |
|10.||Gibson PG, Girgis-Gabardo A, Morris MM, Mattoli S, Kay JM, Dolovich J, et al . Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989;44:693-9. |
|11.||Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al . Eosinophilic inflammation in asthma. N Eng J Med 1990;323:1033-9. |
|12.||Niimi A, Amitani R, Kawai M. Sputum eosinophilia in cough variant asthma. Am Rev Respir Dis 1991;143:A30. |
|13.||Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ. A systemic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med 1997;156:211-6. |
|14.||Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, et al . Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:437-57. |
|15.||Emelyanovo A, Fedoseev G, Abulimity A, Rudinski K, Fedoulov A, Karabanov A, et al . Elevated concentration of exhaled peroxide in asthmatic patients. Chest 2001;120:1136-9. |
|16.||Venge P. Serum measurement of eosinophil cationic protein in bronchial asthma. Clin Exp Allergy 1993;23:3-7. |
|17.||Salem H, Aviado DM. Antitussive drugs. Am J Med Sci 1964;247:585-600. |
|18.||Ojoo JC, Mulrennan S, Kaselik JA, Morice AH, Redington AE. Expired breath condensate pH and expired nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005;60:22-6. |
|19.||Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mill T, Gaston B. Endogenous airway acidification: Implication for asthma pathphysiology. Am J Respir Crit Care Med 2000;161:694-9. |
|20.||Vaughan J, Nagamtrakulpaint L, Pajewski TN, Turner R, Nguyen TA, Smith A, et al . Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur respire J 2003;22:889-94. |
|21.||NHLBI / WHO workshop report 2. Global strategy for asthma management and prevention. National Institutes of Health. National Heart, Lung and Blood Institute: Bethesda; 1997. Publication No 97-4051A. |
|22.||Gallati H, Pracht I. Horseradish peroxidase: Kinetic studies and optimumization of peroxidase activity determination using substrate H2O2 and tetramethyl benzidine. J Clin Chem Clin Biochem 1985;23:453-60. |
|23.||Johnson D, Osborn LM. Cough variant asthma: A review of the clinical literature. J Asthma 1991;28:85-90. |
|24.||Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Godard P, Michel FB. Asthma: A disease remodeling the airways. Allergy 1992;47:3-11. |
|25.||Dohlman AW, Black HR, Royall JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993;148:955-60. |
|26.||Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002;110:349-56. |
|27.||Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS. Tumor necrosis factor alpha / cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 1990;171:2025-41. |
|28.||Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997;10:1235-41. |
|29.||Jobsis Q, Raatgeep HC, Hermans PW, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997;10:519-21. |
|30.||Horvath I, Donnely LE, Kiss A, Kharitonov SA, Lim S, Chung KF, et al . Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respire Crit Care Med 1998;158:1042-6. |
|31.||Glauser FL. Variant asthma. Ann Allergy 1972;30:457-9. |
|32.||Irwin RS, Corrao WM, Pratter MR. Chronic persistent coughing in the adults: The spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123:413-7. |
|33.||Fujimura M, Ogawa H, Yishizawa Y, Nishi K. Comparison of atopic cough with cough variant asthma: Is atopic cough a precursor of asthma? Thorax 2003;58:14-8. |
|34.||Barnes PJ. Reactive oxygen species and airway inflammation. Free Rad Biol Med 1990;9:235-43. |
|35.||Woolcock AJ. How does inflammation cause symptoms? Am J Respir Crit Care Med 1996;153:S21-2. |
|36.||Lallo UG, Barnes PJ, Chung KF. Pathophysiology and clinical presentation of cough. J Allergy Clin Immunol 1996;98:S91-7. |
|37.||Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: Eosinophilic bronchitis without asthma. Lancet 1989;1:1346-8. |
|38.||Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: Examination for variable airflow obstruction and response to corticosteroids. Clin Exp Allergy 1995;25:127-32. |
|39.||Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic non productive cough: In view of effect of bronchodilator therapy. J Asthma 1994;31:463-72. |
|40.||McFadden ER Jr. Exertional dyspnea and cough as preludes to acute attacks of bronchial asthma. N Eng J Med 1975;292:555-9. |
|41.||Cloutier MM, Loughlin GM. Chronic cough in children: A manifestation of airway hyperactivity. Pediatrics 1981;67:6-12. |
|42.||Niimi A, Amitani R, Matsui Y, Sugita T, Suzuki Y, Nishiyama H, et al . Clinical study on cough variant asthma. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30:1077-84. |
|43.||Koh YY, Chae SA, Min KU. Cough variant asthma is associated with a higher wheezing threshold than classic asthma. Clin Exp Allergy 1993;23:696-701. |
|44.||Burney PG. Current questions in the epidemiology of asthma. In: Holgate ST, editor. Asthma: Physiology, Immuno pharmacology and Treatment. Academic Press: London; 1993. p. 3-25. |
|45.||Selroos O, Pietinnalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34. |
|46.||Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen induced increase in non allergic bronchial reactivity. Clin Allergy 1977;7:503-13. |
|47.||Doan T, Patterson R, Greenberger PA. Cough variant asthma: Usefulness of a diagnostic therapeutic trial with prednisone. Ann Allergy 1992;69:505-9. |
|48.||Parks DP, Ahrens RC, Humphries CT, Weinberger MM. Chronic cough in childhood: Approach to diagnosis and treatment. J pediatric 1989;115:856-62. |
|49.||Cheriyan S, Greenberger PA, Patterson R. Outcome of cough variant asthma treated with inhaled steroids. Ann Allergy 1994;73:478-80. |
|50.||McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, et al . Evaluation and outcome of patients with chronic non productive cough using a comprehensive diagnostic protocol. Thorax 1998;53:738-43. |
[Table - 1]
|This article has been cited by|
||Hydrogen peroxide in exhaled breath condensate in patients with asthma: A promising biomarker?
| ||Teng, Y., Sun, P., Zhang, J., Yu, R., Bai, J., Yao, X., Huang, M., (...), Barnes, P.J. |
| ||Chest. 2011; 140(1): 108-116 |
||Hydrogen Peroxide in Exhaled Breath Condensate in Patients with Asthma
| ||Yue Teng,Peili Sun,Jingying Zhang,Rongbin Yu,Jianling Bai,Xin Yao,Mao Huang,Ian M. Adcock,Peter J. Barnes |
| ||Chest. 2011; 140(1): 108 |
|[Pubmed] | [DOI]|
|| Breath analysis of hydrogen peroxide as a diagnostic tool
| ||Stolarek, R., Bialasiewicz, P., Krol, M., Nowak, D. |
| ||Clinica Chimica Acta. 2010; 411(23-24): 1849-1861 |
|| Analysis of exhaled breath condensate in a mixed population of psittacine birds
| ||Foldenauer, U., Simova-Curd, S., Nitzl, D., Bogdanova, A., Zollinger, E., Hatt, J.-M. |
| ||Journal of Avian Medicine and Surgery. 2010; 24(3): 185-191 |
||Breath analysis of hydrogen peroxide as a diagnostic tool
| ||Robert Stolarek,Piotr Bialasiewicz,Maciej Krol,Dariusz Nowak |
| ||Clinica Chimica Acta. 2010; 411(23-24): 1849 |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||7510 |
| Printed||276 |
| Emailed||0 |
| PDF Downloaded||615 |
| Comments ||[Add] |
| Cited by others ||5 |